metastatic melanoma

TIL Immunotherapy Reprograms the Body’s Cells to Become Cancer Killers

TIL Immunotherapy – Innovative Treatment to Fight Melanoma

Conventional cancer therapies are frequently ineffective against metastatic melanoma. TIL (tumor-infiltrating lymphocytes) immunotherapy is a highly progressive, promising treatment, with a high success rate.

Doctors surgically remove part of the tumor and then isolate the tumor-infiltrating lymphocytes (TIL) from it and genetically engineer them to hunt down and attack cancer cells. After administering TIL immunotherapy, the size of the metastasis is often quickly reduced. This treatment is on the forefront of cancer therapies around the world, and it’s only offered by a few medical institutions. Sheba Medical Center performs TIL immunotherapy for metastatic melanoma and is currently studying its clinical use against recalcitrant ovarian cancer.

metastatic melanoma